POLYG

Polygiene

Market Cap 148.9M

Polygiene’s brand is based on its Polygiene Odor Control Technology, with a strategy built on ingredient branding similar to that of Gore-Tex or Windstopper. The company is currently the leading ingredient brand in the sport and outdoor segment, and focuses on premium brands for all kinds of clothing (sports, leisure, fashion, work), footwear and home textiles. Its customers (often called partners by the company) include Adidas, Patagonia, Athleta and Hugo Boss. The list of partners has increased from around 25 (2009) to more than 100 (2017). The additive itself is based on silver salt (silver chloride) made from recycled silver, and is currently used for textiles, foam, plastic or paint. In addition to its additive and ingredient branding, the company uses a comprehensive solution in order to work with the entire value chain and strengthen its competitiveness. These activities include application training for customers’ textile factories, brand training for customers' employees, consumer surveys, responsibility for customer support and complaints related to the Polygiene brand, and labels. The company employs ~20 people and is headquartered in Malmo. In addition, the company has agents and distributors in over 20 locations worldwide and an advisory board. In 2017 sales were SEK 76 million and EBIT SEK -6 million. Polygiene has been traded on First North Stockholm since March 2016.

+ more
Today
Day High
7.50
7.26
Day Low
7.06
Day Open
7.06
Prev Close
7.10
VWAP
7.4
Volume
19K
Turnover
0.139M
Top Broker
VWAP
7.4
Avg Volume
8K
Avg Turnover
0.063M
Top Brokers
NON/AVA
VWAP
7.3
Avg Volume
8K
Avg Turnover
0.055M
Top Brokers
AVA/NON
VWAP
7.4
Avg Volume
8K
Avg Turnover
0.063M
Top Brokers
AVA/NON
52 week summary
Price Range
6.9
Last
13.6
Beta
N/A
Market Cap
148.9M
Total Return
-38.3%
Trailing P/E
-26.9
Div Yield
0.0%
Shares Outstanding
20.5M
Stock Exchange
First North Stockholm
5 day chart Go to advanced chart

Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.

Relative Price Strength
Change 3 Months -5.9%
Change 12 Months -40.1%
Volume Trend
Average Volume 10 vs 60 Days -62.9%
Price VS
52 Week High -46.6%
50 Day Moving Average -4.6%
200 Day moving Average -18.0%

Add article markers

Compare Polygiene to

Prev Close 0 Change 0
High 0 Avg Daily Volume 0
Low 0 Avg Daily Turnover 0
Last updated: 2018-05-10 Source: Redeye
Major Owners Equity Votes
Richard Tooby 10.1%
10.1%
JP Morgan Bank Lux. 6.7%
6.7%
Erik A I Malmö AB 6.6%
6.6%
Clearstream Banking S.A. Lux. 6.5%
6.5%
JPM Chase NA 4.6%
4.6%
Aktia Fund Management 4.1%
4.1%
Jonas Wollin 4.0%
4.0%
Lennart Holm 3.9%
3.9%
Mats Georgson 3.4%
3.4%
Nomura Securities Co Ltd 2.7%
2.7%
Last updated: 2018-05-09 Source: Redeye
Timeframe Transactions Net Shares
Last 12 weeks
1 Purchases
20,000
0 Sales
0
Last 24 weeks
1 Purchases
20,000
0 Sales
0
Report Date Name Position Transaction Shares Chg Est Value (SEK)

Insider trades are behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Source: Millistream
  •  
  • Profitability
  • ROE
  • ROCE
  • ROIC
  • EBITDA margin
  • EBIT margin
  • Net margin
  • Per share data (SEK)
  • EPS
  • EPS adj
  • Dividend
  • Net debt
  • Total shares
  • Valuation
  • EV (SEKm)
  • P/E
  • P/E diluted
  • P/Sales
  • EV/Sales
  • EV/EBITDA
  • EV/EBIT
  • P/BV
  • Capital structure
  • Equity ratio
  • Debt/equity ratio
  • Net debt(SEKm)
  • Capital employed(SEKm)
  • Capital turnover rate
  • (SEKm)
  • Net sales
  • Total operating costs
  • EBITDA
  • Depreciation
  • Amortization
  • Impairment charges
  • EBIT
  • Share in profits
  • Net financial items
  • Exchange rate dif.
  • Pre-tax profit
  • Tax
  • Net earnings
  • (SEKm)
  • Assets
  • Current assets
  • Cash in banks
  • Receivables
  • Inventories
  • Other current assets
  • Current assets
  • Fixed assets
  • Tangible assets
  • Associated comp.
  • Investments
  • Goodwill
  • Cap. exp. for dev.
  • O intangible rights
  • O non-current assets
  • Total fixed assets
  • Deferred tax assets
  • Total (assets)
  • Liabilities
  • Current liabilities
  • Short-term debt
  • Accounts payable
  • O current liabilities
  • Current liabilities
  • Long-term debt
  • O long-term liabilities
  • Convertibles
  • Total Liabilities
  • Deferred tax liab
  • Provisions
  • Shareholders' equity
  • Minority interest (BS)
  • Minority & equity
  • Total liab & SE
  • (SEKm)
  • Net sales
  • Total operating costs
  • Depreciations total
  • EBIT
  • Taxes on EBIT
  • NOPLAT
  • Depreciation
  • Gross cash flow
  • Change in WC
  • Gross CAPEX
  • Free cash flow
  • 2015
  •  
  • 0.0%
  • 27.4%
  • 0.0%
  • 10.9%
  • 10.9%
  • 17.7%
  •  
  • 0.47
  • 0.47
  • 0.00
  •  
  • 19.3
  •  
  • -27.5
  • 0.0
  • 0.0
  • 0.0
  • -0.5
  • -4.9
  • -4.9
  • 0.0
  •  
  • 81.0%
  • 0.0%
  • -28
  • 13
  • 1.0
  • 2015
  •  
  •  
  • 28
  • 14
  • 0
  • 3
  • 45
  •  
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 5
  • 50
  •  
  •  
  • 0
  • 10
  • 0
  • 10
  • 0
  • 0
  • 0
  • 10
  • 0
  • 0
  • 41
  • 0
  • 41
  • 50
  • 2015
  • 52
  • -46
  • 0
  • 6
  • -1
  • 4
  • 0
  • 4
  • -8
  • 0
  • -4
  • 2015 Q2
  • 11
  • -10
  • 1
  • 0
  • 0
  • 0
  • 1
  • 0
  • 0
  • 0
  • 1
  • 0
  • 1
  • 2015 Q3
  • 19
  • -16
  • 3
  • 0
  • 0
  • 0
  • 3
  • 0
  • 0
  • 0
  • 3
  • 0
  • 3
  • 2015 Q4
  • 15
  • -13
  • 2
  • 0
  • 0
  • 0
  • 2
  • 0
  • 0
  • 0
  • 2
  • 4
  • 5
  • 2016
  •  
  • -5.2%
  • -5.7%
  • -15.9%
  • -3.8%
  • -3.8%
  • -3.5%
  •  
  • -0.11
  • -0.11
  • 0.00
  •  
  • 19.6
  •  
  • 214.2
  • -110.5
  • -110.5
  • 3.8
  • 3.5
  • -91.0
  • -91.0
  • 5.7
  •  
  • 72.0%
  • 0.0%
  • -20
  • 21
  • 1.1
  • 2016
  •  
  •  
  • 20
  • 30
  • 0
  • 2
  • 52
  •  
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 6
  • 57
  •  
  •  
  • 0
  • 16
  • 0
  • 16
  • 0
  • 0
  • 0
  • 16
  • 0
  • 0
  • 41
  • 0
  • 41
  • 57
  • 2016
  • 61
  • -64
  • 0
  • -2
  • 0
  • -2
  • 0
  • -2
  • -8
  • 0
  • -11
  • 2016 Q1
  • 13
  • -14
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 2016 Q2
  • 13
  • -15
  • -2
  • 0
  • 0
  • 0
  • -2
  • 0
  • 0
  • 0
  • -2
  • 0
  • -2
  • 2016 Q3
  • 15
  • -15
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 2016 Q4
  • 20
  • -20
  • 1
  • 0
  • 0
  • 0
  • 1
  • 0
  • 0
  • 0
  • 1
  • 0
  • 1
  • 2017
  •  
  • -14.0%
  • -15.8%
  • -25.3%
  • -7.8%
  • -8.0%
  • -7.1%
  •  
  • -0.26
  • -0.26
  • 0.00
  •  
  • 20.5
  •  
  • 238.3
  • -46.3
  • -46.3
  • 3.3
  • 3.1
  • -40.4
  • -39.2
  • 7.0
  •  
  • 67.6%
  • 0.0%
  • -11
  • 25
  • 1.4
  • 2017
  •  
  •  
  • 11
  • 32
  • 0
  • 1
  • 44
  •  
  • 0
  • 0
  • 0
  • 0
  • 0
  • 3
  • 0
  • 3
  • 6
  • 53
  •  
  •  
  • 0
  • 12
  • 5
  • 17
  • 0
  • 0
  • 0
  • 17
  • 0
  • 0
  • 36
  • 0
  • 36
  • 53
  • 2017
  • 76
  • -82
  • 0
  • -6
  • 1
  • -5
  • 0
  • -5
  • 0
  • -3
  • -9
  • 2017 Q1
  • 17
  • -20
  • -3
  • 0
  • 0
  • 0
  • -3
  • 0
  • 0
  • 0
  • -3
  • 0
  • -3
  • 2017 Q2
  • 17
  • -20
  • -4
  • 0
  • 0
  • 0
  • -4
  • 0
  • 0
  • 0
  • -4
  • 0
  • -4
  • 2017 Q3
  • 22
  • -21
  • 1
  • 0
  • 0
  • 0
  • 1
  • 0
  • 0
  • 0
  • 1
  • 0
  • 1
  • 2017 Q4
  • 20
  • -20
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 1
  • 1
  • 2018 E
  • 2018 E
  • 2018 E
  • 2018 Q1 E
  • 2018 Q2 E
  • 2018 Q3 E
  • 2018 Q4 E
  • 2019 E
  • 2019 E
  • 2019 E
  • 2019 Q1 E
  • 2019 Q2 E
  • 2019 Q3 E
  • 2019 Q4 E
  • 2020 E
  • 2020 E
  • 2020 E
  • 2020 Q1 E
  • 2020 Q2 E

Estimated Values are behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Last updated: 2018-05-10 Source: Redeye
Source: Redeye

Presentations, research interviews and videos from our events listed here.

Source: Redeye

Community Posts

Be the first to write something about this company in the community.

Create new post